Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (8)
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
1999 • 1,679 citations
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
1994 • 584 citations
Antiretroviral Drug Resistance Testing in Adults With HIV Infection
1998 • 582 citations
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)
1999 • 228 citations
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
2000 • 216 citations
Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates
1998 • 202 citations
Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients
1996 • 194 citations
Sequence Note: Analysis of HIV Type 1 Protease and Reverse Transcriptase in Antiretroviral Drug-Naive Ugandan Adults
2000 • 57 citations